Sanofi and Regeneron ' s Dupixent Gets More Positive Feedback From U.S. FDA Sanofi and Regeneron ' s Dupixent Gets More Positive Feedback From U.S. FDA

The U.S. Food& Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news